Efficacy and Safety of Oral Semaglutide by Subgroups of Patient Characteristics in PIONEER Phase 3
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme
Diabetes Obes Metab 2022 Apr 04;[EPub Ahead of Print], VR Aroda, R Bauer, E Christiansen, M Haluzík, K Kallenbach, E Montanya, J Rosenstock, JJ MeierFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.